Tocilizumab in the Management of COVID-19: A Preliminary Report

IMPORTANCE: Pneumonia due to COVID-19 can lead to respiratory failure and death due to the development of the acute respiratory distress syndrome. Tocilizumab, a monoclonal antibody targeting the interleukin-6 receptor, is being administered off-label to some patients with COVID-19, and although ear...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Michael, Yoo, Erika J., Baram, Michael, McArthur, Melanie, Skeehan, Connor, Awsare, Bharat, George, Gautam, Summer, Ross, Zurlo, John, Jallo, Jack, Roman, Jesse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Southern Society for Clinical Investigation. Published by Elsevier Inc. 2021
Materias:
Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649658/
https://www.ncbi.nlm.nih.gov/pubmed/33358502
http://dx.doi.org/10.1016/j.amjms.2020.11.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649658/
https://www.ncbi.nlm.nih.gov/pubmed/33358502
http://dx.doi.org/10.1016/j.amjms.2020.11.005

Ejemplares similares